Documente Academic
Documente Profesional
Documente Cultură
Cells
Dr Afshan Sumera
Session outcomes
You should have learnt at end of this session to:
Explain the categories of the various qualitative alterations of
leukocytes.
Describe procedures performed for the detection and
diagnosis of qualitative alterations of leukocytes.
Discuss the disease states/ conditions seen in qualitative
alterations of leukocytes.
Differentiate the peripheral blood findings seen in qualitative
alterations of leukocytes.
Classify various quantitative alterations of leukocytes.
Define relative and absolute values
List the major causes of quantitative alterations of leukocytes
The white cells (Leukocytes)
Eosinophils and basophils are also formed in the marrow in a process similar to that for neutrophils.
Granulopoiesis
Myeloblast Metamyelo
cyte
Proliferative
Promyelo
cyte or mitotic Band
Post-mitotic
pool pool
Myelocyte Segment
ed
Absolute cell counts
Absolute count = absolute cell value =
total leukocyte count x percentage of cell type
A. Lymphocyte
B. Blast
C. Myelocyte
D. Monocyte
E. Promyelocyte
Question
Which of the two cells shown here is most likely to
be phagocytic ?
A. monocyte
B. neutrophil
C. lymphocyte
D. basophil
E. myelocyte
Disorders of neutrophil and monocyte
function
Normalfunction of neutrophils and
monocytes may be divided into three
phases
May-Hegglin anomaly
Rare
Neutrophils contain basophilic RNA inclusions
Mild thrombocytopenia & giant platelets
Autosomal dominant inheritance
Chediak-Higashi syndrome
Autosomal recessive inheritance
Giant granules
Neutropenia, thrombocytopenia
hepatosplenomegaly
Neutrophils-
Morphological abnormalities
basophilic inclusions
toxic changes Dohle body hypersegmented
Metabolic disorders
• Uraemia, eclampsia, acidosis, gout
Neoplasms
• Carcinoma, lymphoma, melanoma
Drugs
• corticosteroids
Parasitic diseases
• Amoebiasis, hookworm, ascariasis, tapeworm infestation, filariasis
Skin diseases
• Psoriasis, pemphigus
Drug sensitivity
Graft-versus-host disease
Basophil leucocytosis (Basophilia)
Above 0.1 x 109/L (uncommon)
Myeloproliferative disorders
Chronic myeloid leukaemia
Polycythaemia vera
Reactive increase
Myxoedema
Chicken pox
Ulcerative colitis
Monocytosis
Above 0.8 x 109/L (usually infrequent)
Cytoplasmic granules
Glandular fever
Fever, sore throat, lymphadenopathy & atypical lymphocytes in blood
Thyrotoxicosis
Infectious mononucleosis
Infection with EBV
Lymphocytosis
Clonal expansion of T cells reacting against B lymphocytes infected with EBV
High titre of heterophile (react with cells of another species) antibody (sheep,
horse or ox red cells)
Infectious mononucleosis- Clinical features
Age 15-40 years (usually teenagers & young adults)
Prodromal period
Lethargy, malaise, headaches, stiff neck & dry cough
Established disease
Bilateral cervical lymphadenopathy (75%)
Generalized lymphadenopathy (50%)
Sore throat with inflamed oral & pharyngeal surfaces (50%)
Fever mild or severe
Morbilliform rash, eye signs (photophobia,
conjuctivitis & periorbital oedema)
Splenomegaly (50%), Hepatomegaly (15%)
Peripheral neuropathy, severe anaemia or purpura
Infectious mononucleosis- Diagnosis
Pleomorphic atypical lymphocytosis
rise in white cell count (e.g. 10-20 x 109/L) with absolute
lymphocytosis
Heterophile antibodies
High titres during 2nd -3rd week & persist for 6 weeks)
Paul-Bunnell test
Monospot test (formalinized horse red cells)
EBV antibody
First 2-3 weeks
Specific antibody to EBV nuclear develops later & persist for life
Haematological abnormalities
Autoimmune hemolytic anaemia (cold type)
thrombocytopenia
Autoimmune thrombocytopenic purpura
Infectious mononucleosis- Reactive lymphocytes
Lymphopenia
Etiology
Bone marrow failure
Corticosteroid & immunosuppressive therapy
Hodgkin’s disease
Irradiation
Immunodeficiency syndromes
HIV infection
Immunodeficiency
Primary Secondary
X-linked agammaglobulinaemia,
Acquired
hypogammaglobulinaemia
B cell B cell Myeloma, Nephrotic
syndrome, protein losing
enteropathy
AIDS, Hodgkin’s
Thymic aplasia
(DiGeorge's syndrome) T cell T cell lymphoma, non-
Hodgkin’s lymphoma,
drugs